nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.00118	0.00118	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PDE4D—prostate cancer	0.00116	0.00116	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—VIP—prostate cancer	0.00115	0.00115	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GNRH1—prostate cancer	0.00115	0.00115	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLXNB1—prostate cancer	0.00114	0.00114	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—LPAR1—prostate cancer	0.00112	0.00112	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GRP—prostate cancer	0.00112	0.00112	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PLCB2—prostate cancer	0.00111	0.00111	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GNG5—prostate cancer	0.0011	0.0011	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRPR—prostate cancer	0.00109	0.00109	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CX3CL1—prostate cancer	0.00108	0.00108	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTHLH—prostate cancer	0.00106	0.00106	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFBR1—prostate cancer	0.00106	0.00106	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL17RD—prostate cancer	0.00106	0.00106	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PDE4D—prostate cancer	0.00105	0.00105	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—prostate cancer	0.00105	0.00105	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKR1C3—prostate cancer	0.00104	0.00104	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRKACB—prostate cancer	0.00104	0.00104	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—PTEN—prostate cancer	0.00102	0.00102	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—THBS1—prostate cancer	0.00101	0.00101	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PPP3CA—prostate cancer	0.00101	0.00101	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GNG5—prostate cancer	0.001	0.001	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—KRAS—prostate cancer	0.000996	0.000996	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ANXA1—prostate cancer	0.000995	0.000995	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRKCZ—prostate cancer	0.000976	0.000976	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—EP300—prostate cancer	0.000974	0.000974	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PTHLH—prostate cancer	0.000962	0.000962	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CG—prostate cancer	0.000954	0.000954	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PARP1—prostate cancer	0.000943	0.000943	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGFR4—prostate cancer	0.000943	0.000943	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JUP—prostate cancer	0.000942	0.000942	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—WNT4—prostate cancer	0.000942	0.000942	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CALCA—prostate cancer	0.000931	0.000931	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—prostate cancer	0.000915	0.000915	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL12—prostate cancer	0.00091	0.00091	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ANXA1—prostate cancer	0.000905	0.000905	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RALBP1—prostate cancer	0.000899	0.000899	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MC2R—prostate cancer	0.000899	0.000899	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PTHLH—prostate cancer	0.000874	0.000874	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CG—prostate cancer	0.000867	0.000867	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CASP9—prostate cancer	0.000857	0.000857	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PRKACB—prostate cancer	0.000855	0.000855	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CALCA—prostate cancer	0.000847	0.000847	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CD—prostate cancer	0.000839	0.000839	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PPP3CA—prostate cancer	0.000833	0.000833	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRKCQ—prostate cancer	0.00083	0.00083	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NGFR—prostate cancer	0.00083	0.00083	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL12—prostate cancer	0.000827	0.000827	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ANXA1—prostate cancer	0.000821	0.000821	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAP3K7—prostate cancer	0.00082	0.00082	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PENK—prostate cancer	0.000801	0.000801	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000797	0.000797	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF10—prostate cancer	0.000789	0.000789	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000786	0.000786	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRB2—prostate cancer	0.000781	0.000781	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—JAK2—prostate cancer	0.00077	0.00077	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CALCA—prostate cancer	0.000769	0.000769	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—MAP2K1—prostate cancer	0.000767	0.000767	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GHR—prostate cancer	0.000764	0.000764	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000763	0.000763	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CD—prostate cancer	0.000762	0.000762	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VAV3—prostate cancer	0.000761	0.000761	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000755	0.000755	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL12—prostate cancer	0.000751	0.000751	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFBR2—prostate cancer	0.00075	0.00075	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000743	0.000743	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ITPR1—prostate cancer	0.000738	0.000738	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NRP1—prostate cancer	0.000733	0.000733	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CB—prostate cancer	0.000731	0.000731	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRB2—prostate cancer	0.00071	0.00071	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1R—prostate cancer	0.000706	0.000706	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CXCL8—prostate cancer	0.000703	0.000703	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—JAK2—prostate cancer	0.000699	0.000699	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—TP53—prostate cancer	0.000697	0.000697	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—VAV3—prostate cancer	0.000692	0.000692	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PRKCQ—prostate cancer	0.000686	0.000686	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000682	0.000682	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VIP—prostate cancer	0.000681	0.000681	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GNRH1—prostate cancer	0.000681	0.000681	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LPL—prostate cancer	0.000677	0.000677	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—IL2—prostate cancer	0.000672	0.000672	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ITPR1—prostate cancer	0.000671	0.000671	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PDGFRB—prostate cancer	0.000671	0.000671	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CB—prostate cancer	0.000664	0.000664	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LPAR1—prostate cancer	0.00066	0.00066	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRP—prostate cancer	0.00066	0.00066	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ITGB3—prostate cancer	0.000654	0.000654	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLCB2—prostate cancer	0.000653	0.000653	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LRP2—prostate cancer	0.000653	0.000653	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRB2—prostate cancer	0.000645	0.000645	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—P4HB—prostate cancer	0.00064	0.00064	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CX3CL1—prostate cancer	0.00064	0.00064	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CXCL8—prostate cancer	0.000638	0.000638	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—IL6—prostate cancer	0.000638	0.000638	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ERBB3—prostate cancer	0.000634	0.000634	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGFR2—prostate cancer	0.000633	0.000633	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—VAV3—prostate cancer	0.000629	0.000629	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000629	0.000629	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDE4D—prostate cancer	0.000623	0.000623	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRB7—prostate cancer	0.000623	0.000623	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL2—prostate cancer	0.00061	0.00061	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ITPR1—prostate cancer	0.00061	0.00061	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TERT—prostate cancer	0.000608	0.000608	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIST1H4H—prostate cancer	0.000607	0.000607	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CXCL8—prostate cancer	0.000607	0.000607	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000604	0.000604	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GNG5—prostate cancer	0.000592	0.000592	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HIF1A—prostate cancer	0.000581	0.000581	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LEP—prostate cancer	0.000567	0.000567	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CAV1—prostate cancer	0.000562	0.000562	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KDR—prostate cancer	0.000556	0.000556	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ESR1—prostate cancer	0.000542	0.000542	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—BAD—prostate cancer	0.000529	0.000529	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTHLH—prostate cancer	0.000516	0.000516	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFBR1—prostate cancer	0.000516	0.000516	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APC—prostate cancer	0.000512	0.000512	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CG—prostate cancer	0.000512	0.000512	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKR1C3—prostate cancer	0.000508	0.000508	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IRS1—prostate cancer	0.000506	0.000506	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EGF—prostate cancer	0.000506	0.000506	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRKACB—prostate cancer	0.000505	0.000505	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PPP3CA—prostate cancer	0.000492	0.000492	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—THBS1—prostate cancer	0.000492	0.000492	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GSK3B—prostate cancer	0.000491	0.000491	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ANXA1—prostate cancer	0.000485	0.000485	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INS—prostate cancer	0.000485	0.000485	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRKCZ—prostate cancer	0.000476	0.000476	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CREBBP—prostate cancer	0.000475	0.000475	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1—prostate cancer	0.000469	0.000469	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—EGFR—prostate cancer	0.000466	0.000466	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000466	0.000466	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PARP1—prostate cancer	0.00046	0.00046	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGFR4—prostate cancer	0.00046	0.00046	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CALCA—prostate cancer	0.000454	0.000454	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAP2K1—prostate cancer	0.000453	0.000453	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CD—prostate cancer	0.00045	0.00045	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CA—prostate cancer	0.000446	0.000446	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SERPINE1—prostate cancer	0.000445	0.000445	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL12—prostate cancer	0.000444	0.000444	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—KRAS—prostate cancer	0.000441	0.000441	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF2—prostate cancer	0.000431	0.000431	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NOS3—prostate cancer	0.000425	0.000425	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CG—prostate cancer	0.000423	0.000423	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASP9—prostate cancer	0.000418	0.000418	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—JAK2—prostate cancer	0.000413	0.000413	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000409	0.000409	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRKCQ—prostate cancer	0.000405	0.000405	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NGFR—prostate cancer	0.000405	0.000405	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CA—prostate cancer	0.000405	0.000405	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MDM2—prostate cancer	0.000403	0.000403	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAP3K7—prostate cancer	0.0004	0.0004	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ERBB2—prostate cancer	0.000398	0.000398	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CB—prostate cancer	0.000392	0.000392	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF10—prostate cancer	0.000385	0.000385	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRB2—prostate cancer	0.000381	0.000381	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL8—prostate cancer	0.000377	0.000377	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	0.000376	0.000376	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	0.000374	0.000374	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	0.000372	0.000372	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VAV3—prostate cancer	0.000371	0.000371	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CDKN1B—prostate cancer	0.000368	0.000368	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	0.000366	0.000366	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AKT1—prostate cancer	0.000364	0.000364	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CASP3—prostate cancer	0.000361	0.000361	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL2—prostate cancer	0.00036	0.00036	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ITPR1—prostate cancer	0.00036	0.00036	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL6—prostate cancer	0.000358	0.000358	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000357	0.000357	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCND1—prostate cancer	0.000351	0.000351	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CTNNB1—prostate cancer	0.000348	0.000348	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1R—prostate cancer	0.000344	0.000344	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	0.000343	0.000343	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—JAK2—prostate cancer	0.000341	0.000341	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP9—prostate cancer	0.000341	0.000341	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CDKN1A—prostate cancer	0.00034	0.00034	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTEN—prostate cancer	0.000339	0.000339	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AKT1—prostate cancer	0.000331	0.000331	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LPL—prostate cancer	0.00033	0.00033	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—IL2—prostate cancer	0.000328	0.000328	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	0.000327	0.000327	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	0.000324	0.000324	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EP300—prostate cancer	0.000323	0.000323	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ITGB3—prostate cancer	0.000319	0.000319	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SRC—prostate cancer	0.000314	0.000314	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	0.000311	0.000311	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ERBB3—prostate cancer	0.000309	0.000309	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGFR2—prostate cancer	0.000309	0.000309	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VEGFA—prostate cancer	0.000306	0.000306	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—STAT3—prostate cancer	0.000303	0.000303	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL2—prostate cancer	0.000298	0.000298	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TERT—prostate cancer	0.000296	0.000296	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HIF1A—prostate cancer	0.000283	0.000283	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MYC—prostate cancer	0.000282	0.000282	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFB1—prostate cancer	0.000281	0.000281	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LEP—prostate cancer	0.000277	0.000277	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EGFR—prostate cancer	0.000276	0.000276	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CAV1—prostate cancer	0.000274	0.000274	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KDR—prostate cancer	0.000271	0.000271	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ESR1—prostate cancer	0.000264	0.000264	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KRAS—prostate cancer	0.00026	0.00026	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—BAD—prostate cancer	0.000258	0.000258	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APC—prostate cancer	0.00025	0.00025	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	0.00025	0.00025	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EGF—prostate cancer	0.000247	0.000247	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IRS1—prostate cancer	0.000247	0.000247	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GSK3B—prostate cancer	0.00024	0.00024	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CA—prostate cancer	0.000239	0.000239	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INS—prostate cancer	0.000236	0.000236	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CREBBP—prostate cancer	0.000232	0.000232	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TP53—prostate cancer	0.000231	0.000231	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1—prostate cancer	0.000229	0.000229	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—EGFR—prostate cancer	0.000228	0.000228	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	0.000221	0.000221	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	0.00022	0.00022	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000217	0.000217	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	0.000217	0.000217	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—KRAS—prostate cancer	0.000215	0.000215	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL6—prostate cancer	0.000212	0.000212	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF2—prostate cancer	0.00021	0.00021	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOS3—prostate cancer	0.000207	0.000207	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JAK2—prostate cancer	0.000202	0.000202	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MDM2—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT1—prostate cancer	0.000195	0.000195	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ERBB2—prostate cancer	0.000194	0.000194	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	0.000191	0.000191	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL8—prostate cancer	0.000184	0.000184	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	0.00018	0.00018	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	0.000178	0.000178	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASP3—prostate cancer	0.000176	0.000176	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL2—prostate cancer	0.000176	0.000176	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL6—prostate cancer	0.000175	0.000175	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCND1—prostate cancer	0.000171	0.000171	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	0.00017	0.00017	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP9—prostate cancer	0.000166	0.000166	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	0.000166	0.000166	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTEN—prostate cancer	0.000165	0.000165	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT1—prostate cancer	0.000161	0.000161	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EP300—prostate cancer	0.000158	0.000158	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SRC—prostate cancer	0.000153	0.000153	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFA—prostate cancer	0.000149	0.000149	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—STAT3—prostate cancer	0.000148	0.000148	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MYC—prostate cancer	0.000137	0.000137	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFB1—prostate cancer	0.000137	0.000137	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EGFR—prostate cancer	0.000134	0.000134	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KRAS—prostate cancer	0.000127	0.000127	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	0.000117	0.000117	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TP53—prostate cancer	0.000113	0.000113	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL6—prostate cancer	0.000103	0.000103	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT1—prostate cancer	9.53e-05	9.53e-05	CbGpPWpGaD
